The scant data on ethnic differences in the prevalence of congenital hypothyroidism (CH) have generally not taken etiology of CH into account. Our hypothesis is that the prevalence of CH due to thyroid dysgenesis (TD) varies by ethnicity.
Methods:
This case–control study included all patients with CH due to TD (a condition of unknown origin) or to dyshormonogenesis (DH, of known autosomal recessive transmission) between 1987 and 2009. Etiology was established by 99mTc scintigraphy. The parents self-assessed their ethnicity, which we grouped in Caucasian, Hispanic, black, Asian, and Maghreb/Middle East. We compared ethnicity between the 190 patients with TD (147 ectopies, 40 athyreoses, and 3 orthotopic hypoplasias) and the 44 patients with DH. Ethnicity was also compared to the reference population of the city of Montreal. Prevalence odds ratios (POR) were calculated and compared by the bilateral Fisher's exact test.
Results:
The ethnic composition of the DH group was similar to that of the reference population. In blacks, TD prevalence of 1 in 190 (0.5%) was low compared to that of DH (4 in 44; 9.1%; POR 0.06; 95% confidence interval: 0.001–0.56; p = 0.005). In contrast, Caucasians showed an increased TD prevalence of 166 in 190 (87.3%) compared to that of DH (30 in 44; 68.2%; POR 3.21; 95% confidence interval: 1.37–7.34; p = 0.0052). No statistically significant differences were observed between other ethnic groups.
Conclusion:
TD is less prevalent in blacks and more prevalent in Caucasians. Blacks being more genetically diverse, this is an argument for an oligogenic inheritance of susceptibility to TD.
Get full access to this article
View all access options for this article.
References
1.
DeladoeyJ, BelangerN, Van VlietG. 2007. Random variability in congenital hypothyroidism from thyroid dysgenesis over 16 years in Quebec. J Clin Endocrinol Metab, 92:3158–3161.
2.
Van VlietG. 2005. Hypothyroidism in infants and children. BravermannLE, UtigerRD. The Thyroid: A Fundamental and Clinical Text, 9th. Lippincott Williams & Wilkins: New York, 1029–1047.
3.
SchoenEJ, ClappW, ToTT, FiremanBH. 2004. The key role of newborn thyroid scintigraphy with isotopic iodide (123I) in defining and managing congenital hypothyroidism. Pediatrics, 114:e683–e688.
4.
CastanetM, PolakM, Bonaiti-PellieC, LyonnetS, CzernichowP, LegerJ. 2001. Nineteen years of national screening for congenital hypothyroidism: familial cases with thyroid dysgenesis suggest the involvement of genetic factors. J Clin Endocrinol Metab, 86:2009–2014.
5.
AmendolaE, De LucaP, MacchiaPE, TerraccianoD, RosicaA, ChiappettaG, KimuraS, MansouriA, AffusoA, ArraC, MacchiaV, Di LauroR, De FeliceM. 2005. A mouse model demonstrates a multigenic origin of congenital hypothyroidism. Endocrinology, 146:5038–5047.
6.
PerryR, HeinrichsC, BourdouxP, KhouryK, SzotsF, DussaultJH, VassartG, Van VlietG. 2002. Discordance of monozygotic twins for thyroid dysgenesis: implications for screening and for molecular pathophysiology. J Clin Endocrinol Metab, 87:4072–4077.
7.
EugeneD, DjemliA, Van VlietG. 2005. Sexual dimorphism of thyroid function in newborns with congenital hypothyroidism. J Clin Endocrinol Metab, 90:2696–2700.
8.
DeladoeyJ, VassartG, Van VlietG. 2007. Possible non-Mendelian mechanisms of thyroid dysgenesis. Endocr Dev, 10:29–42.
9.
KaisermanI, MaytalA, SiebnerR, SackJ. 1997. Effects of immigration on the incidence of congenital hypothyroidism. Eur J Endocrinol, 137:356–359.
10.
BrownAL, FernhoffPM, MilnerJ, McEwenC, ElsasLS. 1981. Racial differences in the incidence of congenital hypothyroidism. J Pediatr, 99:934–936.
11.
LoreyFW, CunninghamGC. 1992. Birth prevalence of primary congenital hypothyroidism by sex and ethnicity. Hum Biol, 64:531–538.
12.
WallerDK, AndersonJL, LoreyF, CunninghamGC. 2000. Risk factors for congenital hypothyroidism: an investigation of infant's birth weight, ethnicity, and gender in California, 1990–1998. Teratology, 62:36–41.
13.
RosenthalM, AddisonGM, PriceDA. 1988. Congenital hypothyroidism: increased incidence in Asian families. Arch Dis Child, 63:790–793.
14.
DubuisJM, GlorieuxJ, RicherF, DealCL, DussaultJH, Van VlietG. 1996. Outcome of severe congenital hypothyroidism: closing the developmental gap with early high dose levothyroxine treatment. J Clin Endocrinol Metab, 81:222–227.
15.
Team RDC. 2006. R: A Language and Environment for Statistical Computing. Vienna, Austriawww.r-project.org.
LohmuellerKE, IndapAR, SchmidtS, BoykoAR, HernandezRD, HubiszMJ, SninskyJJ, WhiteTJ, SunyaevSR, NielsenR, ClarkAG, BustamanteCD. 2008. Proportionally more deleterious genetic variation in European than in African populations. Nature, 451:994–997.
22.
MeddaE, OlivieriA, StaziMA, GrandolfoME, FazziniC, BasergaM, BurroniM, CacciariE, CalaciuraF, CassioA, ChiovatoL, CostaP, LeonardiD, MartucciM, MoschiniL, PagliardiniS, ParlatoG, PigneroA, PincheraA, SalaD, SavaL, StoppioniV, TancrediF, ValentiniF, VigneriR, SorciniM. 2005. Risk factors for congenital hypothyroidism: results of a population case-control study (1997–2003)Eur J Endocrinol, 153:765–773.
23.
DevosH, RoddC, GagneN, LaframboiseR, Van VlietG. 1999. A search for the possible molecular mechanisms of thyroid dysgenesis: sex ratios, associated malformations. J Clin Endocrinol Metab, 84:2502–2506.
24.
NembhardWN, WangT, LoscalzoML, SalemiJL. 2010. Variation in the prevalence of congenital heart defects by maternal race/ethnicity and infant sex. J Pediatr, 156:259–264.
25.
EnewoldL, ZhuK, RonE, MarrogiAJ, StojadinovicA, PeoplesGE, DevesaSS. 2009. Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980–2005. Cancer Epidemiol Biomarkers Prev, 18:784–791.
26.
GudmundssonJ, SulemP, GudbjartssonDF, JonassonJG, SigurdssonA, BergthorssonJT, HeH, BlondalT, GellerF, JakobsdottirM, MagnusdottirDN, MatthiasdottirS, StaceySN, SkarphedinssonOB, HelgadottirH, LiW, NagyR, AguilloE, FaureE, PratsE, SaezB, MartinezM, EyjolfssonGI, BjornsdottirUS, HolmH, KristjanssonK, FriggeML, KristvinssonH, GulcherJR, JonssonT, RafnarT, HjartarssonH, MayordomoJI, de la ChapelleA, HrafnkelssonJ, ThorsteinsdottirU, KongA, StefanssonK. 2009. Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations. Nat Genet, 41:460–464.
27.
GrantDB, SmithI. 1988. Survey of neonatal screening for primary hypothyroidism in England, Wales, and Northern Ireland 1982–4. Br Med J (Clin Res Ed), 296:1355–1358.
28.
RobertsHE, MooreCA, FernhoffPM, BrownAL, KhouryMJ. 1997. Population study of congenital hypothyroidism and associated birth defects, Atlanta, 1979–1992. Am J Med Genet, 71:29–32.
